Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -0.35% | 62.98 | 1.0% | $472.19m | |
| AMGN | Amgen, Inc. | 0.41% | 241.49 | 1.3% | $448.51m | |
| BIIB | Biogen, Inc. | -0.22% | 285.50 | 1.4% | $387.69m | |
| ILMN | Illumina, Inc. | -0.38% | 324.72 | 3.5% | $323.34m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.14% | 235.83 | 1.9% | $300.14m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.10% | 385.94 | 2.6% | $230.50m | |
| EXAS | EXACT Sciences Corp. | -1.92% | 88.06 | 24.0% | $205.44m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.68% | 113.27 | 2.0% | $195.57m | |
| ITCI | Intra-Cellular Therapies, Inc. | -1.43% | 26.25 | 9.0% | $173.00m | |
| INCY | Incyte Corp. | -0.15% | 80.50 | 2.5% | $148.96m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.84% | 127.90 | 14.6% | $138.72m | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | -1.21% | 56.42 | 11.3% | $132.45m | |
| SGEN | Seattle Genetics, Inc. | 1.25% | 109.00 | 6.1% | $122.98m | |
| A | Agilent Technologies, Inc. | 0.79% | 90.17 | 1.6% | $113.52m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.97% | 88.27 | 4.3% | $108.30m |
Company Profile
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.